Get started
Author

Joshua S. Harris

Observed name: Joshua S Harris
ORCID: 0000-0002-2180-840X
Observed ORCID: 0000-0002-2180-840X
OpenAlex ID: A5105792852
Predicting the Hallucinogenic Potential of Molecules Using Artificial Intelligence
2024 · Fabio Urbina, Thane Jones, et al. · ACS Chemical Neuroscience · 12
PDF
Machine Learning and Large Language Models for Modeling Complex Toxicity Pathways and Predicting Steroidogenesis
2025 · Thomas R. Lane, Patricia A. Vignaux, et al. · Environmental Science & Technology · 8
Near-Term Quantum Classification Algorithms Applied to Antimalarial Drug Discovery
2024 · Matthew A. Dorsey, Kelvin Dsouza, et al. · Journal of Chemical Information and Modeling · 8
PDF
Adverse Outcome Pathway and Machine Learning to Predict Drug Induced Seizure Liability
2025 · Thomas R. Lane, Scott H. Snyder, et al. · ACS Chemical Neuroscience · 7
Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4)
2025 · Lucy Martinez-Guerrero, Patricia A. Vignaux, et al. · Molecular Pharmaceutics · 5
DDI–CYP: Metabolism ensemble models for drug-drug interaction predictions
2025 · Jason T. Wong, Joshua S. Harris, et al. · Drug Metabolism and Disposition · 3
PDF
Enzyme replacement therapy for CLN1 batten disease that crosses the blood-brain-barrier
2026 · Renuka Raman, Ben Horst, et al. · Molecular Genetics and Metabolism · 2
Experimental and computational approaches for evaluating molecule interactions with equilibrative nucleoside transporters 1 and 2
2025 · Lucy J. Martinez-Guerrero, Patricia A. Vignaux, et al. · Journal of Pharmacology and Experimental Therapeutics · 2
PDF
Machine learning modeling of zebrafish toxicity endpoints after exposure to PROTACs
2025 · Christopher Yogodzinski, Joshua S Harris, et al. · Toxicological Sciences · 1
Applicability domain-expansion studies for machine learning models reveal new inhibitors of CYP2B6
2025 · Patricia A. Vignaux, Joshua S. Harris, et al. · Drug Metabolism and Disposition · 1
PDF
Discovery of a selective 5-HT2C agonist by generative machine learning using MegaSyn with applications to treating opioid use disorder
2025 · Thane Jones, Joshua S. Harris, et al. · Neurotherapeutics · 1
PDF
In Silico ADME/Tox in the Generative AI Paradigm
2024 · Sean Ekins, Thomas R. Lane, et al. · CRC Press eBooks · 1
Uncertainty Quantification with Domain Classification Models for Acetylcholinesterase Inhibition
2026 · Joshua S. Harris, Patricia A. Vignaux, et al. · Journal of Chemical Information and Modeling
MegaTrans—machine learning models for drug transporters corresponding to the FDA guidance
2026 · Patricia A. Vignaux, Melanie Tojong, et al. · Drug Metabolism and Disposition
MegaEye: Applying multiple machine learning approaches to identify oral compounds with ocular bioactivity
2025 · Fabio Urbina, Scott H. Greenwald, et al. · Artificial Intelligence in the Life Sciences
MegaSyn for Generative Molecule Design
2024 · Joshua S. Harris, Fabio Urbina, et al. · CRC Press eBooks
The Future of Generative Drug Discovery
2024 · Fabio Urbina, Joshua S. Harris, et al. · CRC Press eBooks
Works count: 17
Citation count: 51
H-index: 5
I10-index: 1
Year
Topic
Type